Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thromboprophylaxis in Lower Limb Immobilisation (TiLLI): a Multicentre Study Comprising Two Linked Open Label Phase III Randomised Controlled Trials Evaluating the Effectiveness and Cost Effectiveness of Different Methods of Pharmacological Prophylaxis for Patients With Temporary Lower Limb Immobilisation.

NCT06370273 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT06370273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06370273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thromboprophylaxis in Lower Limb Immobilisation (TiLLI): a Multicentre Study Comprising Two Linked Open Label Phase III Randomised Controlled Trials Evaluating the Effectiveness and Cost Effectiveness of Different Methods of Pharmacological Prophylaxis for Patients With Temporary Lower Limb Immobilisation.
Lead sponsor
Queen Mary University of London
Phase
Phase 3
Overall status
Recruiting
Start date
November 12, 2024
Completion date
August 31, 2028
Enrollment
10,044 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

injury leg, thrombosis